Autotransfusion after coronary artery bypass surgery: is there any benefit?
Postoperative salvage autotransfusion of shed mediastinal blood, using the cardiotomy reservoir, is an inexpensive technique whose efficacy and safety are evaluated in this study. We randomized 75 consecutive patients into two groups. The autotransfusion group (n = 42) received autotransfusion after the completion of the coronary artery bypass grafting (CABG) until the drainage was < or = 50 mL per hour for 2 consecutive hours. The control group (n = 33) was treated with standard chest drainage. Both groups received homologous blood transfusion when the hematocrit fell below 30%. Packed red cells were required post-operatively in 84.8% of the control group and 80.9% of the autotransfusion group (p = NS). Postoperative colloid fluid replacement (excluding autotransfusion fluid) did not differ significantly between the groups. The prothrombin time was significantly higher in the autotransfusion group 24 hours postoperatively (p = 0.03). The fibrin degradation products were elevated only in the serum of the autotransfusion patients (p < 0.002). More febrile patients were seen in the autotransfusion group although not significantly more than the controls. The autotransfusion group received more red cells than the control group, but it lost more red cells in the mediastinal drains. In conclusion, the autotransfusion of shed mediastinal blood has not proved beneficial in reducing the postoperative requirements in homologous blood in patients undergoing coronary artery bypass grafting (CABG).
Bouboulis
N
N
Cardiothoracic Department, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
Kardara
M
M
Kesteven
P J
PJ
Jayakrishnan
A G
AG
D016063:Blood Loss, Surgical; D001803:Blood Transfusion; D001804:Blood Transfusion, Autologous / Q000009:adverse effects; D015505:Chest Tubes; D003250:Constriction; D001026:Coronary Artery Bypass / Q000379:methods; D017707:Erythrocyte Transfusion; D005069:Evaluation Studies as Topic; D005260:Female; D005334:Fever / Q000209:etiology; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005440:Fluid Therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011517:Prothrombin Time; D012449:Safety; D013530:Surgical Wound Infection / Q000209:etiology; D013997:Time Factors
D005338:Fibrin Fibrinogen Degradation Products